Literature DB >> 22873111

Long-term disease-free survival in three ovarian cancer patients with a single relapse.

C Y Chen1, H P Chang, K K Ng, C C Wang, C H Lai, A Chao.   

Abstract

Recurrent ovarian cancer with long-term survival is uncommon and often associated with poor prognosis. We report three cases of patients with advanced ovarian cancer who have achieved long-term disease-free survival following a single prior relapse. Case 1 relapsed with a localized bulky tumor and received a complete surgical resection and chemotherapy. Case 2 had a persistent central pelvic tumor after debulking surgery and second-line chemotherapy, and yet achieved excellent control with concurrent chemoradiation to the true pelvis. Case 3 relapsed with paraaortic lymph node metastasis and probable lung metastasis (subsequently negated by positron emission tomography) and received chemotherapy alone. These three patients have since remained disease-free for 13, 12, and seven years, respectively, since their first relapse. We conclude that select patients can obtain long-term disease-free survival after the first relapse by accurate restaging and aggressive multimodality treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873111

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

Review 1.  Latest research and treatment of advanced-stage epithelial ovarian cancer.

Authors:  Robert L Coleman; Bradley J Monk; Anil K Sood; Thomas J Herzog
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

2.  Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression.

Authors:  Jie Qin; Yan Liu; Yongkui Lu; Meiling Liu; Manli Li; Juan Li; Lijuan Wu
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

3.  miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway.

Authors:  Junhui Zhou; Caixia Zhang; Bo Zhou; Daqiong Jiang
Journal:  Int J Mol Med       Date:  2019-01-29       Impact factor: 4.101

4.  MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.

Authors:  Geyan Wu; Aibin Liu; Jinrong Zhu; Fangyong Lei; Shu Wu; Xin Zhang; Liping Ye; Lixue Cao; Shanyang He
Journal:  Oncotarget       Date:  2015-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.